雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

New Developments in CKD-MBD. Efficacy and safety of antiosteoporotic agents in CKD. James Junichiro 1 1Division of Blood Purification Therapy, Niigata University Medical and Dental Hospital, Japan. pp.1831-1837
Published Date 2014/11/28
DOI https://doi.org/10.20837/4201412087
  • Abstract
  • Look Inside
  • Reference

 The risk of fragility fracture is considerably high among patients with chronic kidney disease. The drugs that reduce the risk of fragility fracture are anti-osteoporotic agents. Recently, many newly developed anti-osteoporotic agents have become available at bedside and now we have much more choices. We must be careful to use them appropriately for those with chronic kidney disease because some of them are contraindication for this disease condition.



基本情報

電子版ISSN 印刷版ISSN 0917-5857 医薬ジャーナル社

関連文献

もっと見る

文献を共有